Background
Ramsay Health Care Ltd (RHC), an ASX-listed private-hospital operator, sought orders under ss 411 and 1319 of the Corporations Act 2001 (Cth) to convene a meeting of ordinary shareholders to consider a proposed demerger of Ramsay Générale de Santé SA (Ramsay Santé). RHC’s indirect wholly owned subsidiary, Ramsay Health Care (UK) Ltd, held 52.79% of Ramsay Santé, which is listed in Paris and operates independently of RHC.
The proposed transaction would be implemented through an interdependent capital reduction and scheme of arrangement. Eligible RHC shareholders would receive 0.25 Ramsay Santé security for every RHC share, rounded down. Subject to an ASX foreign exempt listing, the distribution was expected to be in CHESS depositary interests; otherwise, shareholders would receive Ramsay Santé ordinary shares. Ineligible overseas shareholders, certain small shareholders who did not opt out, and the Ramsay Employee Equity Trustee would instead receive sale proceeds through a sale facility.
The Court’s Holding
Black J made the requested orders at the first court hearing, convening the scheme meeting and making associated orders. The Court held that the statutory and procedural preconditions for the exercise of its discretion under s 411 were met: RHC was a Pt 5.1 body, the proposal was an arrangement within s 411, it was bona fide and properly proposed, ASIC had the required opportunity to consider the materials, and there was no apparent reason the scheme could not later be approved if the required majorities were obtained.
The Court accepted that the scheme could be used to require shareholders to take an in-specie distribution of Ramsay Santé securities rather than cash, subject to shareholder and court approval. It found that the treatment of overseas and small shareholders, CARES holders, employee equity arrangements, and the proposed supplementary performance-rights award to RHC’s CEO did not require separate classes or otherwise justify refusing to convene the meeting. The Court also regarded additional disclosure about RHC losing its controlling interest in Ramsay Santé as important and sufficient to provide fuller information to shareholders.
Key Takeaways
- This was a first-hearing decision: the Court did not finally approve the demerger, but permitted shareholders to vote on it.
- The capital reduction and scheme were interdependent, allowing the Court to assess the arrangements as a whole at the later approval hearing.
- Different sale-facility treatment for ineligible overseas and small shareholders did not, on these facts, require separate voting classes.
Why It Matters
The decision illustrates the Court’s gatekeeping role at the first stage of a scheme of arrangement. The question was whether the proposal was fit to be put to shareholders and was capable of later approval—not whether the Court should finally implement the transaction.
It also confirms that a scheme may facilitate a demerger through an in-specie distribution where shareholder consent is needed to replace an entitlement to cash with securities, provided the scheme materials adequately disclose the transaction and its consequences.